| 产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
|---|---|---|---|---|
| A998690 | Anti-F11 / Factor XI Reference Antibody (osocimab), Anti-F11 / Factor XI Reference Antibody (osocimab), |
|||
| A998691 | Anti-F12 / Factor XII Reference Antibody (garadacimab), Anti-F12 / Factor XII Reference Antibody (garadacimab), |
|||
| A998692 | Anti-F8 / Factor VIII Reference Antibody (Novo Nordisk patent anti-Factor VIII), Anti-F8 / Factor VIII Reference Antibody (Novo Nordisk patent anti-Factor VIII), |
|||
| A998693 | Anti-F9 / Factor IX Reference Antibody (emicizumab), Anti-F9 / Factor IX Reference Antibody (emicizumab), |
|||
| A666731 | Anti-Factor IX & Factor X Reference Antibody (Emicizumab), Target:FactorIX&FactorX,Uniprot:P00740&P00742,Species:Human,isotype:IgG-like Anti-Factor IX & Factor X Reference Antibody (Emicizumab), Target:FactorIX&FactorX,Uniprot:P00740&P00742,Species:Human,isotype:IgG-like |
|||
| A998694 | Anti-FAP Reference Antibody (sibrotuzumab), Anti-FAP Reference Antibody (sibrotuzumab), |
|||
| A998695 | Anti-FceR2 / CD23 Reference Antibody (lumiliximab), Anti-FceR2 / CD23 Reference Antibody (lumiliximab), |
|||
| A998696 | Anti-FcgR2a / CD32a Reference Antibody (VIB9600), Anti-FcgR2a / CD32a Reference Antibody (VIB9600), |
|||
| A998697 | Anti-FcgR3a / CD16a Reference Antibody (AFM13), Anti-FcgR3a / CD16a Reference Antibody (AFM13), |
|||
| A998698 | Anti-FcRL5 / IRTA2 Reference Antibody (cevostamab), Anti-FcRL5 / IRTA2 Reference Antibody (cevostamab), |
|||
| A998699 | Anti-FcRL5 / IRTA2 Reference Antibody (DFRF4539A), Anti-FcRL5 / IRTA2 Reference Antibody (DFRF4539A), |
|||
| A998700 | Anti-FcRn (FCGRT & B2M) Reference Antibody (batoclimab), Anti-FcRn (FCGRT & B2M) Reference Antibody (batoclimab), |
|||
| A998701 | Anti-FcRn (FCGRT & B2M) Reference Antibody (nipocalimab), Anti-FcRn (FCGRT & B2M) Reference Antibody (nipocalimab), |
|||
| A998702 | Anti-FcRn (FCGRT & B2M) Reference Antibody (orilanolimab), Anti-FcRn (FCGRT & B2M) Reference Antibody (orilanolimab), |
|||
| A998703 | Anti-FcRn (FCGRT & B2M) Reference Antibody (rozanolixizumab), Anti-FcRn (FCGRT & B2M) Reference Antibody (rozanolixizumab), |
|||
| A998704 | Anti-FGF19 Reference Antibody (1A6), 1mg/mL in PBS Anti-FGF19 Reference Antibody (1A6), 1mg/mL in PBS |
|||
| A998705 | Anti-FGF2 Reference Antibody (HuGAL-F2), Anti-FGF2 Reference Antibody (HuGAL-F2), |
|||
| A998706 | Anti-FGF23 Reference Antibody (burosumab), Anti-FGF23 Reference Antibody (burosumab), |
|||
| A998707 | Anti-FGFR1 / CD331 Reference Antibody (Lilly patent anti-FGFR-1), Anti-FGFR1 / CD331 Reference Antibody (Lilly patent anti-FGFR-1), |
|||
| A998708 | Anti-FGFR2 / CD332 Reference Antibody (aprutumab), Anti-FGFR2 / CD332 Reference Antibody (aprutumab), |